BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37381056)

  • 21. Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.
    Honoré C; Caruso F; Dartigues P; Benhaim L; Chirica M; Goéré D; Elias D
    Anticancer Res; 2015 Sep; 35(9):4943-7. PubMed ID: 26254392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei).
    Barrios P; Losa F; Gonzalez-Moreno S; Rojo A; Gómez-Portilla A; Bretcha-Boix P; Ramos I; Torres-Melero J; Salazar R; Benavides M; Massuti T; Aranda E
    Clin Transl Oncol; 2016 May; 18(5):437-48. PubMed ID: 26489426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomyxoma peritonei induced by low-grade appendiceal mucinous neoplasm accompanied by rectal cancer: a case report and literature review.
    Ning S; Yang Y; Wang C; Luo F
    BMC Surg; 2019 Apr; 19(1):42. PubMed ID: 31023277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report.
    Ponzini F; Kowal L; Ghafoor M; Goldberg A; Chan J; Lamm R; Cannaday SM; Richard SD; Nevler A; Lavu H; Bowne WB; Rosenblum NG
    World J Surg Oncol; 2022 Mar; 20(1):78. PubMed ID: 35272690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.
    Baratti D; Kusamura S; Milione M; Pietrantonio F; Caporale M; Guaglio M; Deraco M
    Ann Surg Oncol; 2016 Dec; 23(13):4222-4230. PubMed ID: 27352203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed Tomography Follow-Up Assessment of Patients with Low-Grade Appendiceal Mucinous Neoplasms: Evaluation of Risk for Pseudomyxoma Peritonei.
    Tiselius C; Kindler C; Shetye J; Letocha H; Smedh K
    Ann Surg Oncol; 2017 Jul; 24(7):1778-1782. PubMed ID: 28474197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety in the use of intraperitoneal hyperthermia chemotherapy and peritoneal cytoreductive surgery for pseudomyxoma peritonei from appendiceal neoplasm: A systematic review.
    Floriano I; Silvinato A; Reis JC; Cafalli C; Bernardo WM
    Clinics (Sao Paulo); 2022; 77():100039. PubMed ID: 35576869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.
    Legué LM; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
    Clin Colorectal Cancer; 2019 Mar; 18(1):1-7. PubMed ID: 30611664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms.
    Evans T; Aziz O; Chakrabarty B; Wilson MS; Malcomson L; Lavelle C; O'Dwyer ST
    Eur J Surg Oncol; 2021 Jan; 47(1):188-193. PubMed ID: 33092969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.
    Shih IM; Yan H; Speyrer D; Shmookler BM; Sugarbaker PH; Ronnett BM
    Am J Surg Pathol; 2001 Aug; 25(8):1095-9. PubMed ID: 11474297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms.
    van Eden WJ; Kok NFM; Snaebjornsson P; Jóźwiak K; Woensdregt K; Bottenberg PD; Boot H; Aalbers AGJ
    BJS Open; 2019 Jun; 3(3):376-386. PubMed ID: 31183454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy.
    Sutton PA; O'Dwyer ST; Barriuso J; Aziz O; Selvasekar CR; Renehan AG; Wilson MS
    Surg Oncol; 2021 Sep; 38():101572. PubMed ID: 33915487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidentally found mucinous epithelial tumors of the appendix with or without pseudomyxoma peritonei: diagnostic and therapeutic algorithms based on current evidence.
    Ceelen W; De Man M; Willaert W; van Ramshorst GH; Geboes K; Hoorens A
    Acta Chir Belg; 2021 Aug; 121(4):225-234. PubMed ID: 33904809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
    Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
    Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxoma.
    Proesmans V; Vandaele T; Van Slambrouck J; Wolthuis A; D Hoore A; Dekervel J; Van Cutsem E; Dresen R; De Hertogh G; Degezelle K; Van Raemdonck D; Nafteux P; Ceulemans LJ
    Int J Hyperthermia; 2022; 39(1):1153-1157. PubMed ID: 36049823
    [No Abstract]   [Full Text] [Related]  

  • 37. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
    J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin.
    Järvinen P; Ristimäki A; Kantonen J; Aronen M; Huuhtanen R; Järvinen H; Lepistö A
    Int J Colorectal Dis; 2014 Aug; 29(8):999-1007. PubMed ID: 24965858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel.
    Rauwerdink P; Brosens LAA; van Diepen KK; Ghedri ON; Kranenburg O; Boerma D; Witkamp AJ; van Grevenstein HMU
    World J Surg Oncol; 2022 May; 20(1):147. PubMed ID: 35538541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series.
    Guaglio M; Sinukumar S; Kusamura S; Milione M; Pietrantonio F; Battaglia L; Guadagni S; Baratti D; Deraco M
    Ann Surg Oncol; 2018 Apr; 25(4):878-884. PubMed ID: 29270877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.